Vera Therapeutics VERA Total debt

Total debt at other companies

Vertex PharmaceuticalsVRTX

$1.98B+29.5%

Travere Therapeutics, Inc.TVTX

$15.58M-82.6%

Aurinia PharmaceuticalsAUPH

$80.62M-17.7%

Climb Bio, Inc.CLYM

$479K+1.1%

Jade BiosciencesJBIO

$808K+159%

Viridian Therapeutics, Inc.VRDN

$114.36M+395%

FAQ

What is Vera Therapeutics's total debt?

Vera Therapeutics (VERA) reported total debt of $75.03M in Q1 2026.

How has Vera Therapeutics's total debt changed year-over-year?

Vera Therapeutics's total debt increased by 37.8% year-over-year, from $54.47M to $75.03M.

What is the long-term trend for Vera Therapeutics's total debt?

Over 4 years (2021 to 2025), Vera Therapeutics's total debt has grown at a 54.9% compound annual growth rate (CAGR), from $13.42M to $77.31M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.